{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:43Z","timestamp":1787020843202,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010721","name":"Ironwood Pharmaceuticals, Incorporated","doi-asserted-by":"publisher","award":["ESR-15-11Q77"],"award-info":[{"award-number":["ESR-15-11Q77"]}],"id":[{"id":"10.13039\/100010721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1944-5","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T06:02:23Z","timestamp":1561788143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of an interactive voice response system and smartphone application in the identification of gout flares"],"prefix":"10.1186","volume":"21","author":[{"given":"Nada","family":"Elmagboul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Mudano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Redden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cooper","family":"Filby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted R.","family":"Mikuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-8078","authenticated-orcid":false,"given":"Kenneth G.","family":"Saag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,29]]},"reference":[{"issue":"11","key":"1944_CR1","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/art.24209","volume":"59","author":"H. RALPH Schumacher","year":"2008","unstructured":"Schumacher HR Jr, Becker MA, Wortmann RL, MacDonald PA, Hunt B, Streit J, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum. 2008;59:1540\u20138.","journal-title":"Arthritis & Rheumatism"},{"issue":"10","key":"1944_CR2","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1002\/art.27600","volume":"62","author":"Alexander So","year":"2010","unstructured":"So A, De Meulemeester M, Pikhlak A, Y\u00fccel AE, Richard D, Murphy V, et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study. Arthritis Rheum. 2010;62:3064\u201376.","journal-title":"Arthritis & Rheumatism"},{"key":"1944_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cct.2018.03.015","volume":"68","author":"S. Timilsina","year":"2018","unstructured":"Timilsina S, Brittan K, O'Dell J, Brophy M, Davis-Karim A, Henrie A, et al. Design and rationale for the veterans affairs \u201ccooperative study program 594 comparative effectiveness in gout: allopurinol vs. febuxostat\u201d trial. Contemp Clin Trials. 2018;68:102\u20138.","journal-title":"Contemporary Clinical Trials"},{"issue":"3","key":"1944_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/art.33412","volume":"64","author":"H. Ralph Schumacher","year":"2012","unstructured":"Schumacher HR Jr, Sundy JS, Terkeltaub R, Knapp HR, Mellis SJ, Stahl N, et al. Rilonacept (Interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012;64:876\u201384.","journal-title":"Arthritis & Rheumatism"},{"issue":"Suppl 2","key":"1944_CR5","first-page":"540.1-540","volume":"74","author":"K. Saag","year":"2015","unstructured":"Saag K, Fitz-Patrick D, Kopicko J, Fung M, Bhakta N, Adler S, et al. FRI0320 Lesinurad, a selective URIC acid reabsorption inhibitor, in combination with allopurinol: results from a phase III study in gout patients having an inadequate response to standard of care (clear 1). Ann Rheum Dis. 2015;74:540.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1944_CR6","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/ar2978","volume":"12","author":"MA Becker","year":"2010","unstructured":"Becker MA, Schumacher HR, Espinoza LR, Wells AF, MacDonald P, Lloyd E, et al. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Res Ther. 2010;12:R63.","journal-title":"Arthritis Res Ther"},{"key":"1944_CR7","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005;353:2450\u201361.","journal-title":"N Engl J Med"},{"issue":"9","key":"1944_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrrheum.2017.126","volume":"13","author":"Nicola Dalbeth","year":"2017","unstructured":"Dalbeth N, Bardin T, Doherty M, Liot\u00e9 F, Richette P, Saag KG, et al. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the gout, hyperuricemia and crystal-associated disease network (G-CAN). Nat Rev Rheumatol. 2017;13:561\u20138.","journal-title":"Nature Reviews Rheumatology"},{"key":"1944_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/M16-0570","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Harris RP, Forciea MA. Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166:58\u201368.","journal-title":"Ann Intern Med"},{"key":"1944_CR10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64:1431\u201346.","journal-title":"Arthritis Care Res."},{"issue":"1","key":"1944_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2016","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76:29\u201342.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"1944_CR12","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/ard.2010.144063","volume":"70","author":"N. Schlesinger","year":"2011","unstructured":"Schlesinger N, Mysler E, Lin H-Y, De Meulemeester M, Rovensky J, Arulmani U, et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann Rheum Dis. 2011;70:1264\u201371.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1944_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijmedinf.2016.06.021","volume":"94","author":"Amy D. Nguyen","year":"2016","unstructured":"Nguyen AD, Baysari MT, Kannangara DR, Tariq A, Lau AY, Westbrook JI, et al. Mobile applications to enhance self-management of gout. Int J Med Inform. 2016;94:67\u201374.","journal-title":"International Journal of Medical Informatics"},{"key":"1944_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1475-925X-10-24","volume":"10","author":"MN Boulos","year":"2011","unstructured":"Boulos MN, Wheeler S, Tavares C, Jones R. How smartphones are changing the face of mobile and participatory healthcare: an overview, with example from eCAALYX. Biomed Eng Online. 2011;10:24.","journal-title":"Biomed Eng Online"},{"issue":"5","key":"1944_CR15","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.2196\/jmir.9751","volume":"20","author":"Pernille Lunde","year":"2018","unstructured":"Lunde P, Nilsson BB, Bergland A, Kv\u00e6rner KJ, Bye A. The effectiveness of smartphone apps for lifestyle improvement in noncommunicable diseases: systematic review and meta-analyses. J Med Internet Res. 2018;20:e162.","journal-title":"Journal of Medical Internet Research"},{"key":"1944_CR16","doi-asserted-by":"publisher","first-page":"e26554","DOI":"10.1002\/pbc.26554","volume":"64","author":"LA Jibb","year":"2017","unstructured":"Jibb LA, Stevens BJ, Nathan PC, Seto E, Cafazzo JA, Johnston DL, et al. Implementation and preliminary effectiveness of a real-time pain management smartphone app for adolescents with cancer: a multicenter pilot clinical study. Pediatr Blood Cancer. 2017;64:e26554.","journal-title":"Pediatr Blood Cancer"},{"key":"1944_CR17","doi-asserted-by":"crossref","unstructured":"W. Benjamin Nowell, Michelle Thai,Carole Wiedmeyer, Kelly Gavigan, Shilpa Venkatachalam, Seth Ginsberg, Jeffery Curtis. Digital interventions to build a patient registry for rheumatology research. Rheum Dis Clin North Am.\u00a02019;45:173\u201386.","DOI":"10.1016\/j.rdc.2019.01.009"},{"key":"1944_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11136-015-1162-9","volume":"25","author":"AV Bennett","year":"2016","unstructured":"Bennett AV, Keenoy K, Shouery M, Basch E, Temple LK. Evaluation of mode equivalence of the MSKCC bowel function instrument, LASA quality of life, and subjective significance questionnaire items administered by web, interactive voice response system (IVRS), and paper. Qual Life Res. 2016;25:1123\u201330.","journal-title":"Qual Life Res"},{"key":"1944_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0029-6554(03)00161-1","volume":"51","author":"H Lee","year":"2003","unstructured":"Lee H, Friedman ME, Cukor P, Ahern D. Interactive voice response system (IVRS) in health care services. Nurs Outlook. 2003;51:277\u201383.","journal-title":"Nurs Outlook"},{"key":"1944_CR20","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s10461-016-1432-8","volume":"21","author":"A Daftary","year":"2017","unstructured":"Daftary A, Hirsch-Moverman Y, Kassie GM, Melaku Z, Gadisa T, Saito S, et al. A qualitative evaluation of the acceptability of an interactive voice response system to enhance adherence to isoniazid preventive therapy among people living with HIV in Ethiopia. AIDS Behav. 2017;21:3057\u201367.","journal-title":"AIDS Behav"},{"key":"1944_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/art.40381","volume":"70","author":"AL Gaffo","year":"2018","unstructured":"Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS, et al. Brief report: validation of a definition of flare in patients with established gout. Arthritis Rheumatol. 2018;70:462\u20137.","journal-title":"Arthritis Rheumatol"},{"key":"1944_CR22","first-page":"917","volume":"2010","author":"PY Yen","year":"2010","unstructured":"Yen PY, Wantland D, Bakken S. Development of a customizable health IT usability evaluation scale. AMIA Annu Symp Proc. 2010;2010:917\u201321.","journal-title":"AMIA Annu Symp Proc"},{"key":"1944_CR23","doi-asserted-by":"crossref","unstructured":"Senn SS. Cross-over trials in clinical research, West Sussex: John Wiley & Sons Ltd; 2002.","DOI":"10.1002\/0470854596"},{"key":"1944_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/03630269.2015.1025141","volume":"39","author":"CR Jonassaint","year":"2015","unstructured":"Jonassaint CR, Shah N, Jonassaint J, De Castro L. Usability and feasibility of an mHealth intervention for monitoring and managing pain symptoms in sickle cell disease: the Sickle Cell Disease Mobile application to Record Symptoms via Technology (SMART). Hemoglobin. 2015;39:162\u20138.","journal-title":"Hemoglobin."},{"key":"1944_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12937-018-0315-4","volume":"17","author":"GL Ambrosini","year":"2018","unstructured":"Ambrosini GL, Hurworth M, Giglia R, Trapp G, Strauss P. Feasibility of a commercial smartphone application for dietary assessment in epidemiological research and comparison with 24-h dietary recalls. Nutr J. 2018;17:5.","journal-title":"Nutr J"},{"key":"1944_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11904-009-0028-6","volume":"6","author":"KE Schroder","year":"2009","unstructured":"Schroder KE, Johnson CJ. Interactive voice response technology to measure HIV-related behavior. Curr HIV\/AIDS Rep. 2009;6:210\u20136.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1944_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1357633X15621848","volume":"23","author":"V Isetta","year":"2017","unstructured":"Isetta V, Torres M, Gonz\u00e1lez K, Ruiz C, Dalmases M, Embid C, et al. A new mHealth application to support treatment of sleep apnoea patients. J Telemed Telecare. 2017;23:14\u20138.","journal-title":"J Telemed Telecare"},{"key":"1944_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3414\/ME14-01-0106","volume":"55","author":"S Nishiguchi","year":"2016","unstructured":"Nishiguchi S, Ito H, Yamada M, Yoshitomi H, Furu M, Ito M, et al. Self-assessment of rheumatoid arthritis disease activity using a smartphone application. Methods Inf Med. 2016;55:65\u20139.","journal-title":"Methods Inf Med"},{"key":"1944_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/bmjinnov-2015-000098","volume":"2","author":"JA Anguera","year":"2016","unstructured":"Anguera JA, Jordan JT, Castaneda D, Gazzaley A, Are\u00e1n PA. Conducting a fully mobile and randomised clinical trial for depression: access, engagement and expense. BMJ Innov. 2016;2:14\u201321.","journal-title":"BMJ Innov"},{"issue":"9","key":"1944_CR30","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.2196\/mhealth.9656","volume":"6","author":"Michelle Crouthamel","year":"2018","unstructured":"Crouthamel M, Quattrocchi E, Watts S, Wang S, Berry P, Garcia-Gancedo L, et al. Using a ResearchKit smartphone app to collect rheumatoid arthritis symptoms from real-world participants: feasibility study. JMIR mHealth uHealth. 2018;6:e177.","journal-title":"JMIR mHealth and uHealth"},{"issue":"suppl 3","key":"1944_CR31","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.1111\/j.1526-4637.2007.00378.x","volume":"8","author":"Alicia Heapy","year":"2007","unstructured":"Heapy A, Sellinger J, Higgins D, Chatkoff D, Bennett TC, Kerns RD. Using interactive voice response to measure pain and quality of life. Pain Med. 2007;8:S145\u201354.","journal-title":"Pain Medicine"},{"key":"1944_CR32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.urology.2012.07.038","volume":"80","author":"TA Skolarus","year":"2012","unstructured":"Skolarus TA, Holmes-Rovner M, Hawley ST, Dunn RL, Barr KL, Willard NR, et al. Monitoring quality of life among prostate cancer survivors: the feasibility of automated telephone assessment. Urology. 2012;80:1021\u20136.","journal-title":"Urology."},{"key":"1944_CR33","doi-asserted-by":"publisher","first-page":"e015597","DOI":"10.1136\/bmjopen-2016-015597","volume":"7","author":"A Kassavou","year":"2017","unstructured":"Kassavou A, Sutton S. Reasons for non-adherence to cardiometabolic medications, and acceptability of an interactive voice response intervention in patients with hypertension and type 2 diabetes in primary care: a qualitative study. BMJ Open. 2017;7:e015597.","journal-title":"BMJ Open"},{"key":"1944_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1527-5299.2007.06412.x","volume":"13","author":"M Heisler","year":"2007","unstructured":"Heisler M, Halasyamani L, Resnicow K, Neaton M, Shanahan J, Brown S, et al. \u201cI am not alone\u201d: the feasibility and acceptability of interactive voice response-facilitated telephone peer support among older adults with heart failure. Congest Heart Fail. 2007;13:149\u201357.","journal-title":"Congest Heart Fail"},{"key":"1944_CR35","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1503\/cmaj.081659","volume":"180","author":"N Oake","year":"2009","unstructured":"Oake N, van Walraven C, Rodger MA, Forster AJ. Effect of an interactive voice response system on oral anticoagulant management. CMAJ. 2009;180:927\u201333.","journal-title":"CMAJ."},{"key":"1944_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3122\/jabfm.17.3.190","volume":"17","author":"DL Hahn","year":"2004","unstructured":"Hahn DL, Plane MB. Feasibility of a practical clinical trial for asthma conducted in primary care. J Am Board Family Pract. 2004;17:190\u20135.","journal-title":"J Am Board Family Pract"},{"key":"1944_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/AJP.0000000000000171","volume":"31","author":"C Lalloo","year":"2015","unstructured":"Lalloo C, Jibb LA, Rivera J, Agarwal A, Stinson JN. \u201cThere\u2019s a pain app for that\u201d: review of patient-targeted smartphone applications for pain management. Clin J Pain. 2015;31:557\u201363.","journal-title":"Clin J Pain"},{"issue":"8","key":"1944_CR38","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.2196\/mhealth.7229","volume":"5","author":"Ran A Cai","year":"2017","unstructured":"Cai RA, Beste D, Chaplin H, Varakliotis S, Suffield L, Josephs F, et al. Developing and evaluating JIApp: acceptability and usability of a smartphone app system to improve self-management in young people with juvenile idiopathic arthritis. JMIR mHealth uHealth. 2017;5:e121.","journal-title":"JMIR mHealth and uHealth"},{"issue":"2","key":"1944_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/ACM.0000000000001205","volume":"92","author":"E. Ray Dorsey","year":"2017","unstructured":"Dorsey ER, Yvonne Chan YF, McConnell MV, Shaw SY, Trister AD, Friend SH. The use of smartphones for health research. Acad Med. 2017;92:157\u201360.","journal-title":"Academic Medicine"},{"key":"1944_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cct.2007.02.007","volume":"28","author":"K Abu-Hasaballah","year":"2007","unstructured":"Abu-Hasaballah K, James A, Aseltine RH Jr. Lessons and pitfalls of interactive voice response in medical research. Contemp Clin Trials. 2007;28:593\u2013602.","journal-title":"Contemp Clin Trials"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1944-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1944-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1944-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T19:14:38Z","timestamp":1593285278000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1944-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1944-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,29]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The trial was approved by the Institutional Review Boards at the two academic medical centers conducting this study, University of Alabama at Birmingham (UAB) and at the University of Nebraska Medical Center (UNMC, Omaha, NE).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T. Mikuls had a research support from Ironwood\/Astra Zeneca and Horizon. K. Saag had a research support from Ironwood, Horizon, Takeda, and Sobi and is a consultant at Horizon, Sobi, Shanton, and Takeda. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}